Inventor · disambiguated record
Doris Stoermer
Also filed as: STOERMER DORIS · STOERMER DORIS D
19 granted patents·5 pending applications·555 citations·filing 2002–2018
95Inventor score
Files with3M INNOVATIVE PROPERTIES CO11GUILFORD PHARM INC7STOERMER DORIS4HAYS DAVID S1TSUKAMOTO TAKASHI1
Top patents by PatentIndex Score
24 records- 0198US6797718B2Ether substituted imidazopyridines3M INNOVATIVE PROPERTIES CO·Filed 2003·Granted Sep 28, 2004·212 cites·22 claims
- 0297US7220758B2Ether substituted imidazopyridines3M INNOVATIVE PROPERTIES CO·Filed 2006·Granted May 22, 2007·68 cites·33 claims
- 0396US7884207B2Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines3M INNOVATIVE PROPERTIES CO·Filed 2005·Granted Feb 8, 2011·73 cites·17 claims
- 0495US7125890B2Ether substituted imidazopyridines3M INNOVATIVE PROPERTIES CO·Filed 2004·Granted Oct 24, 2006·67 cites·15 claims
- 0594US8951528B2Immune response modifier conjugatesSTOERMER DORIS·Filed 2007·Granted Feb 10, 2015·44 cites·7 claims
- 0692US9006264B2Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines3M INNOVATIVE PROPERTIES CO·Filed 2013·Granted Apr 14, 2015·7 cites·20 claims
- 0792US8541438B2Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridinesSTOERMER DORIS·Filed 2010·Granted Sep 24, 2013·9 cites·19 claims
- 0891US9550773B2Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines3M INNOVATIVE PROPERTIES CO·Filed 2015·Granted Jan 24, 2017·5 cites·17 claims
- 0989US6586623B2Thiol-based NAALADase inhibitorsGUILFORD PHARM INC·Filed 2002·Granted Jul 1, 2003·25 cites·25 claims
- 1088US10472420B2Immune response modifier conjugates3M INNOVATIVE PROPERTIES CO·Filed 2015·Granted Nov 12, 2019·8 cites·10 claims
- 1187US8168802B2Ring closing and related methods and intermediatesHAYS DAVID S·Filed 2006·Granted May 1, 2012·7 cites·21 claims
- 1282US10005772B2Immune response modifier compositions and methodsSTOERMER DORIS·Filed 2007·Granted Jun 26, 2018·4 cites·11 claims
- 1380US6740777B2Thiolalkyl benzoic acid derivativesGUILFORD PHARM INC·Filed 2002·Granted May 25, 2004·13 cites·17 claims
- 1478US6812364B2Thiol-based NAALADase inhibitorsGUILFORD PHARM INC·Filed 2003·Granted Nov 2, 2004·8 cites·10 claims
- 1570US6884907B2Hydroxamic acids and acyl hydroxamines as naaladase inhibitorsGUILFORD PHARM INC·Filed 2002·Granted Apr 26, 2005·5 cites·18 claims
- 1670US2018222906A1Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines3M INNOVATIVE PROPERTIES CO·Filed 2018·Application pending·0 cites
- 1767US9938275B2Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines3M INNOVATIVE PROPERTIES CO·Filed 2017·Granted Apr 10, 2018·0 cites·20 claims
- 1861US10144735B2Immune response modifier compositions and methods3M INNOVATIVE PROPERTIES CO·Filed 2018·Granted Dec 4, 2018·0 cites·13 claims
- 1960US6992215B2Thiol-based NAALADase inhibitorsGUILFORD PHARM INC·Filed 2004·Granted Jan 31, 2006·0 cites·10 claims
- 2058US2006135812A1Thiol-based NAALADase inhibitorsTSUKAMOTO TAKASHI·Filed 2006·Application pending·0 cites
- 2154US7138543B2Thiolalkyl benzoic acid derivativesGUILFORD PHARM INC·Filed 2004·Granted Nov 21, 2006·0 cites·16 claims
- 2247US2006009525A1Hydroxamic acids and acyl hydroxamines as NAALADase inhibitorsGUILFORD PHARM INC·Filed 2005·Application pending·0 cites
- 2343US2009270443A11-amino imidazo-containing compounds and methodsSTOERMER DORIS·Filed 2005·Application pending·0 cites
- 2443US2006142202A1Compositions and methods for targeted delivery of immune response modifiers3M INNOVATIVE PROPERTIES CO·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Doris Stoermer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →